EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Effectiveness of antibiotic prophylaxis for ventilator-associated pneumonia in acute brain injury: a systematic review and meta-analysis

Marcelo Costa, Aurelia Incristi, Justin Lindsay, Filipe Virgilio Ribeiro, Kristen Paradine, Tate Barney, Rahul Manne, Gustavo de Oliveira Almeida, Amelia Liu, Raphael Bertani, Wellingson Silva Paiva

Infection · 2026-04 · 54 (2) · 781-793

DOI: 10.1007/s15010-025-02709-3 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Infection, online erschienen am 11.12.2025. Verfasst von Marcelo Costa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Wright State University Boonshoft School of Medicine, Fairborn, OH, USA. costa.10@wright.edu. Hauptthemen laut MEDLINE: Pneumonia, Ventilator-Associated, Antibiotic Prophylaxis, Anti-Bacterial Agents, Brain Injuries. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ventilator-associated pneumonia (VAP) affects 30-50% of mechanically ventilated patients with acute brain injury (ABI), exceeding general ICU rates (10-20%) due to aspiration risks and immunosuppression, prolonging ICU stays and morbidity. Although short-course antibiotic prophylaxis (AP; e.g., ceftriaxone) targets early VAP, efficacy in ABI remains debated amid mixed evidence, resistance concerns, and non-endorsement by IDSA/ATS guidelines. METHODS: We searched PubMed, Cochrane Library, and Web of Science (inception to October 2024) for RCTs and non-RCTs on systemic AP (short-course beta-lactams) for VAP prevention in ABI (TBI, SAH, stroke, post-arrest coma) requiring ventilation ≥ 48 h. PRIMARY OUTCOMES: early-onset VAP (≤ 96 h), late-onset VAP (> 96 h), overall VAP, ICU mortality. Secondaries: mechanical ventilation duration, ICU/hospital length of stay (LOS), time to first VAP. Random-effects meta-analysis; heterogeneity via I2; risk of bias (RoB 2.0/ROBINS-I). RESULTS: Ten studies (5 RCTs [n = 586], 5 non-RCTs [n = 1,087]; total n = 1,673) were included. AP reduced overall VAP (RR = 0.65, 95% CI: 0.48-0.90, P < 0.001; I2 = 75.9%) and early-onset VAP (RR = 0.41, 95% CI: 0.33-0.52, P < 0.001; I2 = 0%; events: 88/754 AP vs. 240/832 control). No effect on late-onset VAP (RR = 1.13, 95% CI: 0.72-1.78, P = 0.07; I2 = 64.8%) or ICU mortality (RR = 0.91, 95% CI: 0.76-1.08, P = 0.27; I2 = 0%). Secondaries: Reduced ICU LOS (MD = - 2.05 days, 95% CI: - 3.73 to - 0.37, P = 0.01; I2 = 46%) and hospital LOS (MD = - 5.02 days, 95% CI: - 9.20 to - 0.85, P = 0.02; I2 = 70.8%); no difference in ventilation duration (MD = - 1.36 days, 95% CI: - 2.91 to 0.19, P = 0.09) or time to VAP (MD = 1.04 days, 95% CI: - 0.87 to 2.95, P = 0.29). RCTs showed low-moderate bias; non-RCTs moderate-serious (confounding). CONCLUSION: Short-course AP reduces early/overall VAP and LOS in ABI without impacting late VAP or mortality, supporting targeted use in high-risk cases (e.g., GCS < 8) per stewardship principles. However, heterogeneity, resistance gaps, and guideline caution warrant larger RCTs with non-ABI comparatives to mitigate selection bias and confirm specificity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumonia, Ventilator-AssociatedAntibiotic ProphylaxisAnti-Bacterial AgentsBrain InjuriesHumansIntensive Care UnitsRespiration, ArtificialLength of StayTreatment Outcome

Stichwörter der Autor:innen

Acute brain injuryAntibiotic prophylaxisICU outcomesMechanical ventilationNeurocritical careVentilator-associated pneumonia

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Wright State University Boonshoft School of Medicine, Fairborn, OH, USA. costa.10@wright.edu.
  • Wright State University Boonshoft School of Medicine, Fairborn, OH, USA.
  • College of Medicine, Barão de Mauá University Center, Ribeirão Preto, SP, Brazil.
  • Department of Neurosurgery, Federal University of Triângulo Mineiro, Uberaba, MG, Brazil.
  • Department of Neurosurgery, University of São Paulo, São Paulo, SP, Brazil.

Zitieren

APA

Costa, M., Incristi, A., Lindsay, J., Virgilio Ribeiro, F., Paradine, K., Barney, T., Manne, R., de Oliveira Almeida, G., Liu, A., Bertani, R., & Silva Paiva, W. (2026). Effectiveness of antibiotic prophylaxis for ventilator-associated pneumonia in acute brain injury: a systematic review and meta-analysis. Infection, 54(2), 781-793. https://doi.org/10.1007/s15010-025-02709-3

Vancouver

Costa M, Incristi A, Lindsay J, Virgilio Ribeiro F, Paradine K, Barney T, et al. Effectiveness of antibiotic prophylaxis for ventilator-associated pneumonia in acute brain injury: a systematic review and meta-analysis. Infection. 2026;54(2):781-793. doi:10.1007/s15010-025-02709-3

BibTeX
@article{Costa2026,
  author = {Costa, Marcelo and Incristi, Aurelia and Lindsay, Justin and Virgilio Ribeiro, Filipe and Paradine, Kristen and Barney, Tate and Manne, Rahul and de Oliveira Almeida, Gustavo and Liu, Amelia and Bertani, Raphael and Silva Paiva, Wellingson},
  title = {Effectiveness of antibiotic prophylaxis for ventilator-associated pneumonia in acute brain injury: a systematic review and meta-analysis},
  journal = {Infection},
  year = {2026},
  volume = {54},
  number = {2},
  pages = {781--793},
  doi = {10.1007/s15010-025-02709-3}
}
Kostenlos starten →